Native Nephrectomy before and after Renal Transplantation in Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD).

J Clin Med

Department of Urology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117 Berlin, Germany.

Published: October 2019

The aim of this study was 1) to evaluate and compare pre-, peri-, and post-operative data of Autosomal Dominant Polycystic Kidney Disease (ADPKD) patients undergoing native nephrectomy (NN) either before or after renal transplantation and 2) to identify advantages of optimal surgical timing, postoperative outcomes, and economical aspects in a tertiary transplant centre. This retrospective analysis included 121 patients divided into two groups-group 1: patients who underwent NN prior to receiving a kidney transplant ( = 89) and group 2: patients who underwent NN post-transplant ( = 32). Data analysis was performed according to demographic patient details, surgical indication, laboratory parameters, perioperative complications, underlying pathology, and associated mortality. There was no significant difference in patient demographics between the groups, however right-sided nephrectomy was performed predominantly within group 1. The main indication in both groups undergoing a nephrectomy was pain. Patients among group 2 had no postoperative kidney failure and a significantly shorter hospital stay. Higher rates of more severe complications were observed in group 1, even though this was not statistically significant. Even though the differences between both groups were substantial, the time of NN prior or post-transplant does not seem to affect short-term and long-term transplantation outcomes. Retroperitoneal NN remains a low risk treatment option in patients with symptomatic ADPKD and can be performed either pre- or post-kidney transplantation depending on patients' symptom severity.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832478PMC
http://dx.doi.org/10.3390/jcm8101622DOI Listing

Publication Analysis

Top Keywords

native nephrectomy
8
nephrectomy renal
8
renal transplantation
8
autosomal dominant
8
dominant polycystic
8
polycystic kidney
8
kidney disease
8
disease adpkd
8
patients underwent
8
patients
7

Similar Publications

Objective: To explore patients' experience of decision making regarding treatment of localised kidney cancer.

Methods: A total of 21 patients with localised kidney cancer, across three countries, participated in either four focus groups or seven semi-structured interviews that lasted on average 2 h. Focus groups and interviews were all conducted in the participants' native language, recorded, transcribed and (if applicable) translated into English.

View Article and Find Full Text PDF

Clinical characteristics and outcomes of kidney transplantation in autosomal dominant polycystic kidney disease patients.

J Nephrol

November 2024

Division of Nephrology, Department of Internal Medicine, College of Medicine, Yonsei University, Seoul, Republic of Korea.

Article Synopsis
  • Kidney transplantation is the best treatment option for autosomal dominant polycystic kidney disease (ADPKD), and this study compares the clinical outcomes of ADPKD patients to non-ADPKD kidney transplant recipients.
  • The research analyzed data from two Korean transplant centers over 15 years and found that ADPKD patients had a higher risk of developing post-transplant diabetes and infections, although their rates of rejection, graft failure, and mortality were similar to non-ADPKD patients.
  • Interestingly, while kidney volume decreased after transplantation, the size of liver cysts increased in ADPKD patients, indicating that kidney size and prior surgeries did not affect overall transplant outcomes.
View Article and Find Full Text PDF

Introduction And Importance: Renal transplant recipients have a higher risk for developing cancers compared to the general population due to high-dose immunosuppression. The risk of renal cell carcinoma (RCC) in native kidneys is 7-fold greater than the general population and development of RCC in an allograft kidney is extremely rare. We report the diagnosis and management of a large RCC in an allograft renal transplant and metastatic disease in a regional lymph node.

View Article and Find Full Text PDF

Introduction: Although living kidney donation is generally considered a safe procedure, it is ethically critical that prospective donors are fully informed before consent. However, prospective donors lack a deep understanding of the donation experience, making the postdonation aftermath feel unanticipated. We sought to gain in-depth qualitative descriptions of the short- and long-term risks and benefits associated with kidney donation among an ethnically diverse group of donors to offer a balanced view of the positive and negative experiences that may occur postdonation.

View Article and Find Full Text PDF
Article Synopsis
  • Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disorder often leading to end-stage renal disease, and this study reviews native nephrectomy (NN) practices over 25 years at a transplant center.
  • A total of 89 out of 152 ADPKD patients who underwent kidney transplantation (KT) also had NN, with most NN being unilateral and planned surgeries showing better outcomes than acute ones.
  • The findings highlight the importance of careful planning and patient-specific strategies in NN for ADPKD due to increased complications associated with acute surgeries.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!